// App-Quantinova.ai

: Absence of nuclear Programmed cell death 4 as an indicator of poor prognosis in uveal melanoma patients

Researchers

Presenter

  • I. Ahmed

Principal Investigators

  • H. Kalirai

  • M. Angi

  • S. Coupland

Medical Centers

  • Liverpool Ocular Oncology Research Group‐Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Uveal melanoma

Biomarkers

  • Cancer antigen 15-3

  • Programmed Cell Death 4

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved